HealthCo Healthcare and Wellness (HCW) H2 2026 earnings summary

Executive summary

• Achieved strong operational performance in FY26 with 100% rent collection and 99% occupancy across a diversified healthcare portfolio valued at up to AUD 1.35 billion as of June 2026.

• Maintained a robust balance sheet with AUD 158 million in cash and undrawn debt, and gearing at 29%, below the target range.

• Advanced resolution of the Healthscope situation, ensuring continuity of healthcare services and progressing lease transitions to alternative operators.

• Portfolio delivered 4.1% like-for-like NOI growth, supported by disciplined balance sheet management.

Financial highlights

• FY26 FFO was AUD 0.04 per unit (AUD 21.9m), impacted by paused distributions from the unlisted healthcare fund; underlying FFO was AUD 0.077 per unit including HCW's share of UHF.

• NTA per unit stood at AUD 1.35 as of June 2026, with a minor decrease from December due to cap rate expansion.

• Portfolio independently valued at up to AUD 1.35 billion, with 74% independently valued including all Healthscope hospitals.

• Asset sales of AUD 77 million completed during the year, supporting liquidity.

Outlook and guidance

• FY27 DPU guidance of AUD 0.06 per unit, and underlying FFO guidance of AUD 0.061 per unit, both contingent on Healthscope resolution.

• FY27 FFO guidance is at least AUD 0.04 per unit.

• Strategic focus on sustainable earnings, distribution growth, and narrowing trading discount to NTA.